Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07820956

Ice Application for Oxacillin-Related Phlebitis and Pain

Conditions: Peripheral Intravenous Phlebitis, Injection Site Pain, Pain

Sex: All
Ages: 20 Years – 60 Years
Healthy volunteers: No
Phase: NA
Enrollment: 86
Sponsor: Central Taiwan University of Science and Technology

Location: Feng Yuan Hospital, Ministry of Health and Welfare Fengyuan

Summary

This randomized controlled trial evaluated whether ice application could reduce pain and peripheral intravenous phlebitis associated with oxacillin administration. Hospitalized patients receiving intravenous oxacillin were assigned to either an ice application group or a control group. In the intervention group, ice was applied to the area around the peripheral intravenous catheter before oxacillin administration. In the control group, a room-temperature water bag was applied in the same manner. Pain after oxacillin administration and signs of phlebitis at the intravenous catheter site were assessed and compared between the two groups. The study aimed to determine whether ice application could provide a simple, non-pharmacological approach to reducing oxacillin-related pain and phlebitis.

Eligibility Criteria

Inclusion Criteria: Adults aged 20 to 60 years. Conscious and able to participate in the study. Intravenous injection site located on either hand. Receiving a single antibiotic medication during the study. Eligible regardless of sex or medical diagnosis. Exclusion Criteria: Dementia. Psychiatric disorders. Skin rash at the study site. Purpura. Pregnancy. Current oral corticosteroid use. Hemodialysis. Administration of a second medication or an injection containing two or more medications during the study. \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07820956). StuddyBuddy aggregates publicly available trial information.